Home / Import refusals / SCS-5607863-8/11/2

FDA Import Refusal SCS-5607863-8/11/2 — Bausch Health Companies Inc.

Bausch Health Companies Inc. — FEI 3002807186

The FDA refused shipment SCS-5607863-8/11/2 from Bausch Health Companies Inc. (Canada) on August 15, 2019. The refused product falls under Drugs and Biologics — DILTIAZEM HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
August 15, 2019
Country
Canada
Product Category
Drugs and Biologics
Product Code
62OCY24 DILTIAZEM HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II)
Charges
75

Recent inspections

  • 1229765 (NAI Fri Jan 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1190487 (NAI Thu Sep 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1108379 (NAI Thu Sep 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1007199 (NAI Fri Feb 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 914426 (VAI Fri Feb 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • AEK-0272725-2/10002/1 (Thu Apr 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-8958101-4/20003/1 (Mon Dec 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-7206171-9/10003/1 (Fri Nov 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-8529827-4/10003/1 (Mon Nov 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • EI5-5600896-6/10002/1 (Fri Nov 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources